Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H21N7O4S.C5H8O3 |
Molecular Weight | 547.584 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)CCC(O)=O.COC1=CC2=NC(=NC(N)=C2C=C1OC)N3CCN(CC3)C(=O)C4=NN=C(O4)SC
InChI
InChIKey=NIDVOMJMOVCWQI-UHFFFAOYSA-N
InChI=1S/C18H21N7O4S.C5H8O3/c1-27-12-8-10-11(9-13(12)28-2)20-17(21-14(10)19)25-6-4-24(5-7-25)16(26)15-22-23-18(29-15)30-3;1-4(6)2-3-5(7)8/h8-9H,4-7H2,1-3H3,(H2,19,20,21);2-3H2,1H3,(H,7,8)
Molecular Formula | C5H8O3 |
Molecular Weight | 116.1152 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C18H21N7O4S |
Molecular Weight | 431.469 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Tiodazosin is a newly developed antihypertensive agent, structurally related to prazosin. Prazosin and tiodazosin administrated intravenously to anesthetized rats, are equally effective hypotensive agents, but that the hypotensive potency of prazosin is greater than that of tiodazosin. However, chronic administration of equivalent doses of the two compounds for 25 and 52 days via the drinking water indicated approximately equivalent, sustained reductions in blood pressure. Furthermore, at the end of the 52-day chronic dosing period tiodazosin caused appreciably less alpha-adrenergic receptor antagonist activity than prazosin as assessed by the norepinephrine dose-pressor response profiles.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Profile of a new prazosin congener, BL-5111A. Studies in the rat. | 1980 Jan-Feb |
|
Non-competitive antagonism of the alpha-adrenoceptor-mediated fast component of contraction of rat aorta, by doxazosin and prazosin. | 1983 Oct |
|
[New hypotensive drugs]. | 1984 Dec 17-31 |
|
Alteration in the pharmacologic activity of alpha 1 adrenergic antagonists by alpha-1-acid glycoprotein. | 1989 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:00:01 GMT 2023
by
admin
on
Fri Dec 15 15:00:01 GMT 2023
|
Record UNII |
21CC6UVV2J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
21312538
Created by
admin on Fri Dec 15 15:00:01 GMT 2023 , Edited by admin on Fri Dec 15 15:00:01 GMT 2023
|
PRIMARY | |||
|
DTXSID20998117
Created by
admin on Fri Dec 15 15:00:01 GMT 2023 , Edited by admin on Fri Dec 15 15:00:01 GMT 2023
|
PRIMARY | |||
|
21CC6UVV2J
Created by
admin on Fri Dec 15 15:00:01 GMT 2023 , Edited by admin on Fri Dec 15 15:00:01 GMT 2023
|
PRIMARY | |||
|
76798-65-7
Created by
admin on Fri Dec 15 15:00:01 GMT 2023 , Edited by admin on Fri Dec 15 15:00:01 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |